Artificial disc device from AxioMed nears trial completion

01/11/2013 | MedCityNews.com

AxioMed Spine expects to complete a pivotal U.S. study of its Freedom Lumbar Disc, which is used to treat patients suffering from degenerative spine disease, before the end of the quarter. The Cleveland company, which has secured $3.6 million in its latest funding round, will use data from the trial to back its FDA clearance application for the device.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ